Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Search results

IntercontinentalExchange (ICE) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
IntercontinentalExchange (ICE) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

The market expects IntercontinentalExchange (ICE) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2026. This widely-known

The Space Race Just Hit a Bottleneck—Who Benefits?
The Space Race Just Hit a Bottleneck—Who Benefits?

One of the space industry's fastest-growing constraints isn't ambition, funding, or even technology. It's access to orbit. Reliable launch capacity is the bottleneck that is shaping competitive

Amazon Deepens AI Push With Expanded Anthropic Deal: What's Ahead?
Amazon Deepens AI Push With Expanded Anthropic Deal: What's Ahead?

Amazon AMZN is deepening its generative-AI footprint after announcing an expanded strategic collaboration with Anthropic on April 20, 2026. Under the agreement, Anthropic has committed to spending

Are You Looking for a High-Growth Dividend Stock?
Are You Looking for a High-Growth Dividend Stock?

Whether it's through stocks, bonds, ETFs, or other types of securities, all investors love seeing their portfolios score big returns. But for income investors, generating consistent cash flow from

Why Capital City Bank (CCBG) is a Great Dividend Stock Right Now
Why Capital City Bank (CCBG) is a Great Dividend Stock Right Now

Whether it's through stocks, bonds, ETFs, or other types of securities, all investors love seeing their portfolios score big returns. But for income investors, generating consistent cash flow from

First Financial Bankshares (FFIN) Could Be a Great Choice
First Financial Bankshares (FFIN) Could Be a Great Choice

Whether it's through stocks, bonds, ETFs, or other types of securities, all investors love seeing their portfolios score big returns. However, when you're an income investor, your primary focus is

Why Chemung Financial (CHMG) is a Top Dividend Stock for Your Portfolio
Why Chemung Financial (CHMG) is a Top Dividend Stock for Your Portfolio

Whether it's through stocks, bonds, ETFs, or other types of securities, all investors love seeing their portfolios score big returns. But when you're an income investor, your primary focus is

QuantumScape Q1 Earnings Beat Estimates on Eagle Line Startup Progress
QuantumScape Q1 Earnings Beat Estimates on Eagle Line Startup Progress

QuantumScape Corporation QS reported a loss of 16 cents per share for the first quarter of 2026, narrower than the Zacks Consensus Estimate of a loss of 18 cents. It delivered an earnings surprise

SNDK's Rides on End-Market Diversification: Is the Model Paying Off?
SNDK's Rides on End-Market Diversification: Is the Model Paying Off?

Sandisk Corporation’s SNDK end-market growth is expanding, highlighting how its diversified model is enhancing revenue resilience and visibility. The company is witnessing strong, broad-based

TIIAY vs. SCMWY: Which Stock Should Value Investors Buy Now?
TIIAY vs. SCMWY: Which Stock Should Value Investors Buy Now?

Investors with an interest in Diversified Communication Services stocks have likely encountered both Telecom Italia (TIIAY) and Swisscom AG (SCMWY). But which of these two stocks is more attractive

BDTX and the CNS-Active EGFR Trend: Why C797S Is the Prize
BDTX and the CNS-Active EGFR Trend: Why C797S Is the Prize

Black Diamond Therapeutics BDTX is building its thesis around a single, brain-penetrant EGFR inhibitor, silevertinib, with early clinical activity across a wide range of EGFR mutations and a safety

Black Diamond's Lead Drug Silevertinib: Key Data, Catalysts, and Risks
Black Diamond's Lead Drug Silevertinib: Key Data, Catalysts, and Risks

Black Diamond Therapeutics BDTX is a clinical-stage oncology company with an investment story that largely runs through a single program: silevertinib, its brain-penetrant, fourth-generation

4 Energy Stocks Likely to Outperform Q1 Earnings Estimates: https://staticx-tuner.zacks.com/images/articles/main/bb/156360.webp
4 Energy Stocks Likely to Outperform Q1 Earnings Estimates

The first-quarter 2026 earnings season is underway, and investors are closely watching the oil and energy space as it moves through an uncertain economic backdrop, ongoing geopolitical tensions and

Video Gaming Industry's $22B AI Profit Boost: ETFs to Tap the Upside
Video Gaming Industry's $22B AI Profit Boost: ETFs to Tap the Upside

The increasing adoption of AI across the video game industry is enhancing its growth outlook, particularly through improved profitability, enhanced efficiency and reduced production costs. According

Should Amphenol Stock Be in Your Portfolio Pre-Q1 Earnings?
Should Amphenol Stock Be in Your Portfolio Pre-Q1 Earnings?

Amphenol APH is set to report its first-quarter 2026 results on April 29.The company expects first-quarter 2026 earnings between 91 cents and 93 cents per share, indicating growth between 44% and

Is Fastly Stock's 5.21X P/S Still Worth it? Buy, Sell or Hold?
Is Fastly Stock's 5.21X P/S Still Worth it? Buy, Sell or Hold?

Fastly FSLY shares are overvalued, as suggested by a Value Score of F. The FSLY stock is trading at a forward 12-month price/sales (P/S) of 5.21X compared with the broader Zacks Computer and

Essex Property to Report Q1 Earnings: Here's What to Expect
Essex Property to Report Q1 Earnings: Here's What to Expect

Essex Property Trust, Inc. ESS is scheduled to report its first-quarter 2026 results on April 28, after market close. The company’s quarterly results are likely to reflect year-over-year growth in

Orion Group to Report Q1 Results: What's in Store for the Stock?
Orion Group to Report Q1 Results: What's in Store for the Stock?

Orion Group Holdings, Inc. ORN is scheduled to report first-quarter 2026 results on April 28, after the closing bell.In the last reported quarter, its adjusted earnings and contract revenues

SYRE Stock Jumps More Than 70% in a Month: What Is Driving This Rally?
SYRE Stock Jumps More Than 70% in a Month: What Is Driving This Rally?

Shares of Spyre Therapeutics SYRE have surged 73% over the past month after the company reported encouraging data from a mid-stage study evaluating its investigational anti-α4β7 drug, SPY001, in

Live Chats Are Now on Threads: Will They Drive META's User Engagement?
Live Chats Are Now on Threads: Will They Drive META's User Engagement?

Meta Platforms META is benefiting from the introduction of live chats on Threads, a move that is poised to significantly enhance user engagement across its platforms.In the fourth quarter of 2025